Reagan-Udall Foundation for the FDA Issues Paper on COVID-19 Lessons Learned: Clinical Evaluation of Therapeutics

The Reagan-Udall Foundation for the FDA, at the request of the US Food and Drug Administration, has released a report that outlines initial lessons learned from the federal government’s and research communities’ COVID-19 response and provides actionable recommendations to enhance the scope, prioritization, and communication of research activities within the context of a public health emergency. The report can be viewed here.

Additional information on the Reagan-Udall public workshop and Long-Term COVID can be found by following the links below:

https://www.appliedclinicaltrialsonline.com/view/warm-and-ready-clinical-trial-sites

https://www.pharmexec.com/view/uncovering-long-term-covid-in-drug-development